← Eichor
Study identifier: NCT06812728 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Neoadjuvant FOLFIRINOX and Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer Patients

Condition: Rectum Cancer  ·  Sponsor: Menoufia University

PhasePhase 2
Planned participants100
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersNo

About this study

A phase II clinical trial compared standard TNT (mFolfox6 and CRT) with preoperative chemoradiotherapy (CRT) with neoadjuvant chemotherapy (CT) containing mFolfirinox in patients with locally advanced rectal cancer.

This description comes directly from the study's public registry record.

Talk to the study team

E Morkos  ·  00201061323285  ·  yoyonagy7@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

MedicineShibīn al Kawm, Menoufia, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06812728